This episode of Oncology Data Advisor features Shreyaskumar Patel, MD in a discussion that covers the changing treatment landscape, adverse events of concern with novel therapies, and advice for members of the cancer care team as they seek to optimize outcomes for patients with GIST.

On this episode of Oncology Data Advisor, AL B. Benson, MD, FACP, FASCO considers recent developments in genomic testing and targeted therapies, supportive care measures that can optimize quality of life, and strategies that can be utilized to improve outcomes of patients with pancreatic cancer.

On this episode of Oncology Data Advisor, Gilles Salles, MD, PhD, discusses the efficacy of newly developed therapies, adverse events associated with these treatments, ongoing research, and advice for clinicians seeking to optimize outcomes for patients with MCL.

On this episode of Oncology Data Advisor, Mitesh J. Borad, MD, shares insights on managing cholangiocarcinoma in a discussion that covers the changing treatment landscape, adverse events of concern with novel therapies, and advice for members of the cancer care team as they seek to optimize outcomes for patients with this disease.

On this bonus episode of Oncology Data Advisor, Bradley McGregor, MD, and Robert Motzer, MD, discuss first-line and second-line treatments for advanced renal cell carcinoma. Also available as a video. Listen now and earn CME/NCPD credit!

On this bonus episode of Oncology Data Advisor, Shailender Bhatia, MD and Ciara Kelly, MBBCh, BAO discuss emerging evidence on immunotherapeutic strategies for advanced MCC and multidisciplinary approaches to monitor and manage immune-related adverse events. Listen now to earn CME/NCPD credit!